Oxalate-induced ceramide accumulation in Madin-Darby canine kidney and LLC-PK1 cells

Kidney International

Volumn 57, Issue 6, 2000, Pages 2403-2411

  Cao, Lu Cheng ^a   Honeyman, Thomas ^a   Jonassen, Julie ^a   Scheid, Cheryl ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Apoptosis; Lipid signals; Oxidant stress; PLA2; Renal epithelial cells

Indexed keywords

CERAMIDE; OXALIC ACID; SPHINGOMYELIN; SPHINGOMYELIN PHOSPHODIESTERASE; TRITIUM;

ADAPTATION; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL GROWTH; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DOG; ENZYME ACTIVITY; KIDNEY CELL; KIDNEY EPITHELIUM; NONHUMAN; PRIORITY JOURNAL; STRESS; SWINE;

EID: 0034036448     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2000.00099.x     Document Type: Article

References (40)

1. 1. KOUL H, KENNINGTON L, NAIR G, HONEYMAN T, MENON M, SCHEID C: Oxalate-induced initiation of DNA synthesis in LLC-PK1 cells, a line of renal epithelial cells. Biochem Biophys Res Commun 205:1632-1637, 1994
2. 2. SCHEID CR, KOUL H, KENNINGTON L, HILL WA, LUBER-NAROD J, JONASSEN J, HONEYMAN T, MENON M: Oxalate-induced damage to renal tubular cells: A review. Scanning Mitrosc 9:1097-1107, 1995
3. 3. SCHEID CR, KOUL H, HILL WA, LUBER-NAROD J, KENNINGTON L, HONEYMAN T, JONASSEN J, MENON M: Oxalate toxicity in LLC-PK1 cells: Role of free radicals. Kidney Int 49:413-419, 1996
4. 4. SCHEID CR, KOUL H, HILL WA, LUBER-NAROD J, JONASSEN J, HONEYMAN T, KENNINGTON L, KOHLI R, HODAPP J, AYVAZIAN P, MENON M: Oxalate toxicity in LLC-PK1 cells, a line of renal epithelial cells. J Urol 155:1112-1116, 1996
5. 5. KOUL H, KENNINGTON L, HONEYMAN T, JONASSEN J, MENON M, SCHEID C: Activation of c-myc gene mediates the mitogenic effects of oxalate in LLC-PK1 cells, a line of renal epithelial cells. Kidney Int 50:1525-1530, 1996
6. 6. JONASSEN JA, COONEY R, KENNINGTON L, GRAVEL K, HONEYMAN T, SCHEID CR: Oxalate-induced changes in the viability and growth of human renal epithelial cells. J Am Soc Nephrol 10:5446-5451, 1999
7. 7. KHAN SR, SHEVOCK PN, HACKETT RL: Acute hyperoxaluria renal injury and calcium oxalate urolithiasis. J Urol 147:226-230, 1992
8. 8. HACKETT RL, SHEVOCK PN, KHAN SR: Alterations in MDCK and LLC-PK1 cells exposed to oxalate and calcium oxalate monohydrate crystals. Scanning Microsc 9:587-596, 1995
9. 9. THAMISELVAN S, HACKETT RL, KHAN SR: Lipid peroxidation in ethylene glycol induced hyperoxaluria and calcium oxalate nephrolithiasis. J Urol 157:1059-1063, 1997
10. 10. THAMILSELVAN S, KHAN SR: Oxalate and calcium oxalate crystals are injurious to renal epithelial cells: Results of in vivo and in vitro studies. J Nephrol 11(Suppl 1):66-69, 1998
11. 11. KURIEN TB, SELVAM R: Induction of lipid peroxidation in calcium oxalate stone formation. Indian J Biochem Biophys 27:450-453, 1989
12. 12. MANDEL N, RIESE R: Crystal-cell interactions: Crystal hinding to rat renal papillary tip collecting duct cells in culture. Am J Kidney Dis 17:402-406, 1991
13. 13. VERKOELEN CF, VAN DER BOOM BG, HOUTSMULLER AB, SCHRODER FH, ROMIJN JC: Increased calcium oxalate monohydrate crystal binding to injured renal tubular epithelial cells in culture. Am J Physiol 274:F958-F965, 1998
14. 14. KHAN SR, COCKRELL CA, FINLAYSON B, HACKETT RL: Crystal retention by injured urothelium of the rat urinary bladder. J Urol 132:153-157, 1984
15. 15. KOHJIMOTO Y, KENNINGTON L, SCHEID CR, HONEYMAN T: The role of phospholipase A2 in the cytotoxic effects of oxalate in cultured renal epithelial cells. Kidney Int 56:1432-1441, 1999
16. 16. SEGER R, KREBS EC: The MAPK signaling cascade. FASEB J 9:726-735, 1995
17. 17. KOLESNICK RN, KRONKE M: Regulation of ceramide production and apoptosis. Annu Rev Physiol 60:643-665, 1998
18. 18. DRESSLER KA, KOLESNICK RN: Ceramide-1 phosphate, a novel phospholipid in human leukemia (HL-60) cells. J Biol Chem 265:14917-14921, 1990
19. 19. PERKY DK, HANNUN YA: The use of diglyceride kinase for quantifying ceramide. Trends Biol Sci 24:226-227, 1999
20. 20. DRESSLER KA, MATHIAS S, KOLESNICK RN: Tumor necrosis factor-alpha activates the sphingomyelin signal transduction pathway in a cell-free system. Science 255:1715-1718, 1992
21. 21. ITAYA K, UI M: A new micromethod for the colorimetric determination of inorganic phosphate. Clin Chim Acta 14:361-366, 1996
22. 22. WALLENSTEIN S, ZUCKER CL, FLEISS JL: Some statistical methods useful in circulation research. Circ Res 47:1-9, 1980
23. 23. WANG TS, AGULIAN K, GIEBISCH G, ARONSON PS: Effects of formate and oxalate on chloride absorption in the rat distal tubule. Am J Physiol 264:F730-F736, 1993
24. 24. COWLEY DM, MCWHINNEY BC, BROWN JM, CHALMERS AH: Effect of citrate on the urinary excretion of calcium and oxalate: Relevance to calcium oxalate nephrolithiasis. Clin Chem 35:23-28, 1989
25. 25. SINGH I: Cytokine-mediated induction of ceramide production is redox-sensitive: Implications to proinflammatory cytokine-mediated apoptosis in demyelinating diseases. J Biol Chem 273:20354-20362, 1998
26. 26. UEDA N, KAUSHAL GP, HONG X: Role of enhanced ceramide generation in DNA damage and cell death in chemical hypoxic injury. Kidney Int 54:399-406, 1998
27. 27. KAMATA H, HIRATA H: Redox regulation of cellular signalling. Cell Signal 11:1-14, 1999
28. 28. DBAIBO GS, OBEID LM, HANNUN YA: Tumor necrosis factor-alpha (TNF-alpha) signal transduction through ceramide: Dissociation of growth inhibitory effects of TNF-alpha from activation of nuclear factor-kappa B. J Biol Chem 268:17762-17766, 1996
29. 29. MAYER M, NOBLE M: N-acetyl DL-cysteine is a pluripotent protector against cell death and enhancer of trophic factor-mediated cell survival in vitro. Proc Natl Acad Sci USA 91:7496-7500, 1994
30. 30. BAUDRY M, ETIENNE S, BRUCE A, PALUCKI M, KACOBSEN E, MALFROY B: Salen-manganese complexes arc superoxide dismutasemimetics. Biochem Biophys Res Commun 192:964-968, 1993
31. 31. JAYADEV S, LINARDIC CM, HANNUN YA: Identification of arachidonic acid as a mediator of sphingomyelin hydrolysis in response to tumor necrosis factor alpha. J Biol Chem 269:5757-5763, 1994
32. 32. HANNUN YA: The sphingomyelin cycle and the second messenger function of ceramide. J Biol Chem 269:3125-3128, 1994
33. 33. GOMEZ-MUNOZ A: Modulation of cell signalling by ceramides. Biochim Biophys Acta 1391:92-109, 1998
34. 34. ZAGER RA, CONRAD DS, BURKHART K: Ceramide accumulation during oxidant renal tubular injury: Mechanisms and potential consequences. J Am Soc Nephrol 9:1670-1680, 1998
35. 35. LIU B, OBEID LM, HANNUN YA: Sphingomyelinases in cell regulation. Semin Cell Dev Biol 8:311-322, 1997
36. 36. VAN ECHTEN-DECKERT MC, ROYHER J, SANDHOFF K, WANG E, MERRILL AH JR: Characterization of ceramide synthesis: A dihydroceramide desaturase introduces the 4,5-trans-double bond of sphingosine at the level of dihydroceramide. J Biol Chem 272:22432-22437, 1997
37. 37. FERNANDEZ-CHECA JC, KAPLOWITZ N, GARCIA-RUIZ C, COLFLI A, MIRANDA M, MARI M, ARDITE E, MORALES A: GSH transport in mitochondria: Defense against TNF-induced oxidative stress and alcohol-induced defect. Am J Physiol 273:G7-G17, 1997
38. 38. SELVAM R, DEVARAJ S: Oxalate binding to rat kidney mitochondria: Induction by oxidized glutathione. Indian J Biochem Biophys 33: 62-65, 1996
39. 39. MUTHUKUMAR A, SELVAM R: Role of glutathione on renal mitochondrial status in hyperoxaluria. Mol Cell Biochem 185:77-84, 1998
40. 40. RICHTER C, GOGVADZE V, LAFFRANCHI R, SCHLAPBACH R, SCHWEIZER M, SUTER M, WALTER P, YATFEE M: Oxidants in mitochondria: From physiology to diseases. Biochim Biophys Acta 1271:66-74, 1995